Business, Energy and Industrial Strategy Committee

Brexit and the implications for UK business: Pharmaceuticals inquiry

Inquiry status: Concluded

Report and Government response published

This is the pharmaceuticals strand of the Committee's Brexit and the implications for UK business inquiry.

The Committee aims to establish how the interests of different sectors should best be pursued both in the negotiating process and post-Brexit and attempts to examine a range of issues relating to market access, non-tariff barriers, regulation, skills, R&D, trade opportunities and transitional arrangements.

Latest evidence

Next meeting(s)

There are currently no public meetings scheduled.

Related inquiries

Receive RSS updates

Share this page